Free Trial

Cytosorbents (CTSO) Stock Forecast & Price Target

+0.03 (+3.25%)
(As of 10:30 AM ET)

Cytosorbents - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 2 Analyst Ratings

Consensus Price Target

124.72% Upside
High Forecast$3.00
Average Forecast$2.00
Low Forecast$1.00
TypeCurrent Forecast
5/30/23 to 5/29/24
1 Month Ago
4/30/23 to 4/29/24
3 Months Ago
3/1/23 to 2/29/24
1 Year Ago
5/30/22 to 5/30/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$2.00$2.50$2.50$5.50
Forecasted Upside124.72% Upside49.03% Upside44.93% Upside61.76% Upside
Get Cytosorbents Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter.

CTSO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CTSO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cytosorbents Stock vs. The Competition

TypeCytosorbentsMedical CompaniesS&P 500
Consensus Rating Score
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside132.02% Upside724.30% Upside10.86% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Recent Analyst Forecasts and Stock Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/15/2024B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$3.00+257.14%
5/7/2024HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Lee
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$1.00+7.53%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 11:17 AM ET.

CTSO Frequently Asked Questions

What is Cytosorbents's stock forecast and purchase recommendation?

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Cytosorbents is $2.00, with a high forecast of $3.00 and a low forecast of $1.00. The consensus rating for Cytosorbents stock is Moderate Buy based on the current 1 hold rating and 1 buy rating for CTSO. Learn more on CTSO's analyst rating history.

Do Wall Street analysts like Cytosorbents more than its competitors?

Analysts like Cytosorbents less than other "medical" companies. The consensus rating score for Cytosorbents is 2.50 while the average consensus rating score for "medical" companies is 2.70. Learn more on how CTSO compares to other companies.

Does Cytosorbents's stock price have much upside?

According to analysts, Cytosorbents's stock has a predicted upside of 125.99% based on their 12-month stock forecasts.

What analysts cover Cytosorbents?

Cytosorbents has been rated by research analysts at B. Riley, and HC Wainwright in the past 90 days.

Stock Forecasts and Research Tools

This page (NASDAQ:CTSO) was last updated on 5/29/2024 by Staff

From Our Partners